DE68925411T2 - Bis-arylphosphatester-Antagonisten vom Thrombocyten aktivierenden Faktor - Google Patents

Bis-arylphosphatester-Antagonisten vom Thrombocyten aktivierenden Faktor

Info

Publication number
DE68925411T2
DE68925411T2 DE68925411T DE68925411T DE68925411T2 DE 68925411 T2 DE68925411 T2 DE 68925411T2 DE 68925411 T DE68925411 T DE 68925411T DE 68925411 T DE68925411 T DE 68925411T DE 68925411 T2 DE68925411 T2 DE 68925411T2
Authority
DE
Germany
Prior art keywords
bis
phosphate ester
activating factor
platelet activating
aryl phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925411T
Other languages
English (en)
Other versions
DE68925411D1 (de
Inventor
Allan Wissner
Kenneth Green
Robert Eugene Schaub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE68925411D1 publication Critical patent/DE68925411D1/de
Publication of DE68925411T2 publication Critical patent/DE68925411T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/62Isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650905Six-membered rings having the nitrogen atoms in the positions 1 and 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
DE68925411T 1988-12-19 1989-11-23 Bis-arylphosphatester-Antagonisten vom Thrombocyten aktivierenden Faktor Expired - Fee Related DE68925411T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/286,193 US4983592A (en) 1988-12-19 1988-12-19 Bis-arylphosphate ester antagonists of platelet activating factor

Publications (2)

Publication Number Publication Date
DE68925411D1 DE68925411D1 (de) 1996-02-22
DE68925411T2 true DE68925411T2 (de) 1996-10-17

Family

ID=23097500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925411T Expired - Fee Related DE68925411T2 (de) 1988-12-19 1989-11-23 Bis-arylphosphatester-Antagonisten vom Thrombocyten aktivierenden Faktor

Country Status (21)

Country Link
US (2) US4983592A (de)
EP (1) EP0374513B1 (de)
JP (1) JP2733351B2 (de)
KR (1) KR0153279B1 (de)
AR (1) AR248027A1 (de)
AT (1) ATE132871T1 (de)
AU (1) AU623716B2 (de)
CA (1) CA2005678A1 (de)
DE (1) DE68925411T2 (de)
DK (1) DK170101B1 (de)
ES (1) ES2083964T3 (de)
FI (1) FI94348C (de)
GR (1) GR3018821T3 (de)
IE (1) IE74204B1 (de)
IL (1) IL92407A (de)
MX (1) MX9203270A (de)
NO (1) NO178305C (de)
NZ (1) NZ231724A (de)
PH (1) PH26906A (de)
PT (1) PT92595B (de)
ZA (1) ZA899695B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234918A (en) * 1988-04-04 1993-08-10 American Cyanamid Company Certain phosphinyl-oxy-phenyl-methyl-pyridinium-hydroxide inner salts useful as antagonists of PAF
US5215975A (en) * 1988-04-04 1993-06-01 American Cyanamid Company Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner salts as PAF antagonists
US5147864A (en) * 1988-12-19 1992-09-15 American Cyanamid Company Bis-arylphosphate ester antagonists of platelet activating factor
US4983592A (en) * 1988-12-19 1991-01-08 American Cyanamid Co. Bis-arylphosphate ester antagonists of platelet activating factor
US5231091A (en) * 1988-12-19 1993-07-27 American Cyanamid Company Bis-arylphosphate ester antagonists of platelet activating factor
US5496855A (en) * 1995-01-27 1996-03-05 Smithkline Beecham Corp. Anti-inflammatory compounds
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7612668A (nl) * 1976-01-06 1977-07-08 Dow Chemical Co Werkwijze voor het bereiden van nieuwe organo- fosforusverbindingen.
US4091095A (en) * 1976-07-06 1978-05-23 Hoechst Aktiengesellschaft Phosphinyl compounds
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
US4456464A (en) * 1982-05-19 1984-06-26 Zoecon Corporation Phenoxy- and pyridyloxy-phenoxyalkyl phosphinates and related sulfur compounds for weed control
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4640913A (en) * 1983-01-10 1987-02-03 American Cyanamid Company Phosphocholine derivatives having antihypertensive action
US4650791A (en) * 1984-01-11 1987-03-17 Takedo Chemical Industries, Ltd. Certain 3-alkoxy-2-cyclic-imido-propyl-phosphate-ethyl-cyclic ammonium hydroxide inner salts which inhibit activities of platelet activating factor
EP0178261A3 (de) * 1984-10-10 1986-12-30 Sandoz Ag Substituierte 2-Furanyl- oder -5-Oxo-2-furanyl-alkoxy-phosphorylalkylcyclimmoniumsalze
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
IT1178709B (it) * 1984-12-05 1987-09-16 Neopharmed Spa Diacilderivati della glicerilfosforilcolina ad attivita'terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
US4762942A (en) * 1984-12-10 1988-08-09 American Cyanamid Co. Antihypertensive phosphate derivatives
US4900731A (en) * 1984-12-10 1990-02-13 American Cyanamid Company Antihypertensive phosphate derivatives
US4827011A (en) * 1984-12-10 1989-05-02 American Cyanamid Company Antihypertensive phosphate derivatives
EP0225129B1 (de) * 1985-11-29 1989-05-24 Takeda Chemical Industries, Ltd. Phospholipidderivate, ihre Herstellung und ihre Verwendung
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4983592A (en) * 1988-12-19 1991-01-08 American Cyanamid Co. Bis-arylphosphate ester antagonists of platelet activating factor
SG43205A1 (en) * 1988-12-19 1997-10-17 American Cyanamid Co A method for the treatment of endotoxic shock in a mammal
US5208223A (en) * 1990-11-13 1993-05-04 American Cyanamid Company Phosphocholine derivative inhibitors of phospholipase A2

Also Published As

Publication number Publication date
US4983592A (en) 1991-01-08
FI896045A0 (fi) 1989-12-18
MX9203270A (es) 1992-09-01
PT92595A (pt) 1990-06-29
US5328901A (en) 1994-07-12
KR900009670A (ko) 1990-07-05
DK170101B1 (da) 1995-05-22
EP0374513A2 (de) 1990-06-27
AR248027A1 (es) 1995-05-31
AU623716B2 (en) 1992-05-21
JP2733351B2 (ja) 1998-03-30
PH26906A (en) 1992-12-03
NO895085L (no) 1990-06-20
ES2083964T3 (es) 1996-05-01
ZA899695B (en) 1990-09-26
EP0374513B1 (de) 1996-01-10
DK641989A (da) 1990-06-20
NZ231724A (en) 1992-09-25
IL92407A (en) 1995-12-31
NO895085D0 (no) 1989-12-18
IE894058L (en) 1990-06-19
NO178305B (no) 1995-11-20
ATE132871T1 (de) 1996-01-15
EP0374513A3 (de) 1991-04-03
FI94348B (fi) 1995-05-15
FI94348C (fi) 1995-08-25
DK641989D0 (da) 1989-12-18
NO178305C (no) 1996-02-28
PT92595B (pt) 1996-06-28
GR3018821T3 (en) 1996-04-30
JPH02221291A (ja) 1990-09-04
IE74204B1 (en) 1997-07-16
DE68925411D1 (de) 1996-02-22
AU4688389A (en) 1990-06-21
CA2005678A1 (en) 1990-06-19
IL92407A0 (en) 1990-07-26
KR0153279B1 (ko) 1998-12-01

Similar Documents

Publication Publication Date Title
DK483189D0 (da) Leukaemi-haemmende faktor
PT87752A (pt) Faktor viii:c-aehnliches molekuel mit koagulationssaktivitaet
DE3855981T2 (de) Zerstäubungstarget aus Mo-Ta oder W-Ta
FI891990A (fi) Jäänmuodostusta estäviä päällystyskoostumuksia
KR900009892A (ko) 분말 코팅
DK731488D0 (da) Delt labyrintpakning
FR2637622B1 (fr) Revetement
ITGE910067A1 (it) Dispositivo per l'agugliatura di falde d'ovatta
DK530888D0 (da) Leukotrien -ltd4- og - ltb4-antagonister
DK354389A (da) Neutrofilaktiverende faktor
DE68925411D1 (de) Bis-arylphosphatester-Antagonisten vom Thrombocyten aktivierenden Faktor
ES2021427B3 (es) Estructuras tridimensionales de hebras interbloqueadas.
DK637888D0 (da) Carboxylsyreestere
DK357989D0 (da) Kabelfoering af traadnet
FI880089A0 (fi) Päällystyslaite
DK637288A (da) Faktor viii inhibitorer
ZA892447B (en) Novel antagonists of platelet activating factor
IT8967675A0 (it) Dispositivo di patinatura
DK93491D0 (da) Selvemulgerende esterforbindelser
ES2013217A4 (es) Composiciones de recubrimiento de poliglicidamida
ITMI911805A0 (it) Inibitori dell'adesione piastrinica al fattore von willebrand e loro uso come farmaci antitrombotici
FI101709B1 (fi) Pinnoitekoostumus
IE891045L (en) Antagonists of platelet activating factor
ES1002367Y (es) Pulverizador de efecto envolvente
SE8700557D0 (sv) Dispenseranordning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee